1 August 2022, 07:00 BST
Restated half year numbers for new reporting structure |
|
As announced in our preliminary full year results in May, we have changed our reporting structure for the year ending 31st March 2023. |
|
Today, we provide restated numbers by business - now also including the half year detail - for the years ending 31st March 2021 and 31st March 2022. Please see the appendix on page 2. |
|
ENDS |
|
Enquiries: |
||
|
Investor Relations |
||
|
Martin Dunwoodie Louise Curran Carla Fabiano |
Director of Investor Relations Senior Investor Relations Manager Senior Investor Relations Manager |
+44 20 7269 8241 +44 20 7269 8235 +44 20 7269 8004 |
|
Johnson Matthey Plc is listed on the London Stock Exchange (JMAT) |
|
Registered in England & Wales number: 00033774 |
|
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10 |
Appendix |
|
Sales (£ million) |
2021/22 |
2020/21 |
|||||
|
1H |
2H |
FY |
1H |
2H |
FY |
||
|
Clean Air |
1,196 |
1,261 |
2,457 |
1,003 |
1,409 |
2,412 |
|
|
PGM Services |
300 |
287 |
587 |
215 |
316 |
531 |
|
|
Catalyst Technologies |
223 |
231 |
454 |
196 |
247 |
443 |
|
|
Hydrogen Technologies |
10 |
15 |
25 |
19 |
22 |
41 |
|
|
Value Businesses¹,² |
181 |
173 |
354 |
172 |
199 |
371 |
|
|
Eliminations |
(55) |
(44) |
(99) |
(45) |
(68) |
(113) |
|
|
Total sales |
1,855 |
1,923 |
3,778 |
1,560 |
2,125 |
3,685 |
|
|
Health (discontinued) |
83 |
79 |
162 |
119 |
118 |
237 |
|
|
Total sales (as reported) |
1,938 |
2,002 |
3,940 |
1,679 |
2,243 |
3,922 |
|
|
Operating profit (£ million) |
2021/22 |
2020/21 |
|||||
|
1H |
2H |
FY |
1H |
2H |
FY |
||
|
Clean Air |
150 |
152 |
302 |
77 |
192 |
269 |
|
|
PGM Services |
167 |
141 |
308 |
78 |
166 |
244 |
|
|
Catalyst Technologies |
30 |
20 |
50 |
10 |
22 |
32 |
|
|
Hydrogen Technologies |
(12) |
(21) |
(33) |
- |
1 |
1 |
|
|
Value Businesses¹,³ |
1 |
11 |
12 |
(2) |
2 |
- |
|
|
Corporate |
(39) |
(47) |
(86) |
(27) |
(46) |
(73) |
|
|
Total operating profit |
297 |
256 |
553 |
136 |
337 |
473 |
|
|
Health (discontinued) |
(4) |
7 |
3 |
15 |
16 |
31 |
|
|
Total operating profit (as reported) |
293 |
263 |
556 |
151 |
353 |
504 |
|
|
Notes: |
||
|
1. |
Value Businesses includes Battery Systems, Medical Device Components, Diagnostic Services, Battery Materials (completion expected summer 2022), Advanced Glass Technologies (divestment completed February 2022), Water and Atmosphere Control Technologies (divestments completed November 2020). |
|
|
2. |
Sales relating to divestments: |
|
|
· |
2021/22 includes Advanced Glass Technologies (1H: £37m, 2H: £25m) and Battery Materials (1H: £6m, 2H: £6m). |
|
|
· |
2020/21 includes Advanced Glass Technologies (1H: £27m, 2H: £39m), Battery Materials (1H: £6m, 2H: £8m) and Other - Water and Atmosphere Control Technologies (1H: £13m, 2H: £4m). |
|
|
3. |
Operating profit relating to divestments: |
|
|
· |
2021/22 includes Advanced Glass Technologies (1H: £10m, 2H: £6m) and Battery Materials (1H: -£17m, 2H: -£5m). |
|
|
· |
2020/21 includes Advanced Glass Technologies (1H: £5m, 2H: £12m), Battery Materials (1H: -£10m, 2H: -£13m) and Other - Water and Atmosphere Control Technologies (1H: £1m, 2H: £nil). |
|